SCHEMBL4668152

SCHEMBL4668152

N#Cc1ccc(COCCN2CC3CN(CCNC(=O)O)CC(C2)O3)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.44
CCR5 P51681 1/20 0.40
CD274 Q9NZQ7 1/20 0.39
HTR1A P08908 5/20 0.39
DRD2 P14416 4/20 0.39
HTR7 P34969 4/20 0.39
HTR6 P50406 4/20 0.39
GBA1 P04062 1/20 0.39
UGCG Q16739 1/20 0.39
GBA2 Q9HCG7 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
HRH1 P35367 4/20 0.37
DRD4 P21917 2/20 0.37
HTR2A P28223 2/20 0.37
OPRM1 P35372 2/20 0.37
CCR3 P51677 2/20 0.37
HRH2 P25021 3/20 0.36
CACNA1F O60840 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
CNR1 P21554 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4669235 0.91 KCNH2 (0.44) KCNH2CD274HTR1ADRD2HTR7
SCHEMBL4669237 0.87 KCNH2 (0.52) KCNH2HRH1HRH2HRH3KCNA5
SCHEMBL4134193 0.86 KCNH2 (0.53) KCNH2CD274HRH1HRH2HRH3
SCHEMBL4125747 0.86 KCNH2 (0.48) KCNH2CD274DRD2L3MBTL1CNR1
SCHEMBL1619458 0.86 FAAH (0.46) KCNH2CD274DRD2DRD3PKM
SCHEMBL4137801 0.85 KCNH2 (0.59) KCNH2HRH1HRH2HRH3
SCHEMBL2967590 0.85 KCNH2 (0.44) KCNH2CD274HTR1ADRD2HTR7
SCHEMBL5316269 0.84 HTR1A (0.45) KCNH2HTR1ADRD2HTR7HTR6
SCHEMBL4668117 0.83 KCNH2 (0.40) KCNH2CCR5HTR1ADRD2HTR7
SCHEMBL5316850 0.82 HTR1A (0.49) HTR1ADRD2HTR7HTR6L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893619-A1 NEW OXABISPIDINE COMPOUNDS FOR THE TREATMENT OF CARDIAC ARRHYTMIAS AstraZeneca AB (SE) 2008-03-05 EP claimed
WO-2006135316-A1 New oxabispidine compounds for the treatment of cardiac arrhythmias ASTRAZENECA AB (SE) 2006-12-21 WO claimed